BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fonteh AN, Cipolla M, Chiang AJ, Edminster SP, Arakaki X, Harrington MG. Polyunsaturated Fatty Acid Composition of Cerebrospinal Fluid Fractions Shows Their Contribution to Cognitive Resilience of a Pre-symptomatic Alzheimer's Disease Cohort. Front Physiol 2020;11:83. [PMID: 32116789 DOI: 10.3389/fphys.2020.00083] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Li S, Luo Z, Zhang R, Xu H, Zhou T, Liu L, Qu J. Distinguishing Amyloid β-Protein in a Mouse Model of Alzheimer's Disease by Label-Free Vibrational Imaging. Biosensors (Basel) 2021;11:365. [PMID: 34677321 DOI: 10.3390/bios11100365] [Reference Citation Analysis]
2 Pautova A, Burnakova N, Revelsky A. Metabolic Profiling and Quantitative Analysis of Cerebrospinal Fluid Using Gas Chromatography-Mass Spectrometry: Current Methods and Future Perspectives. Molecules 2021;26:3597. [PMID: 34208377 DOI: 10.3390/molecules26123597] [Reference Citation Analysis]
3 Dulewicz M, Kulczyńska-Przybik A, Słowik A, Borawska R, Mroczko B. Fatty Acid Binding Protein 3 (FABP3) and Apolipoprotein E4 (ApoE4) as Lipid Metabolism-Related Biomarkers of Alzheimer's Disease. J Clin Med 2021;10:3009. [PMID: 34300173 DOI: 10.3390/jcm10143009] [Reference Citation Analysis]
4 Gupta S, Dasmahapatra AK. Destabilization of Aβ fibrils by omega-3 polyunsaturated fatty acids: a molecular dynamics study. J Biomol Struct Dyn 2021;:1-18. [PMID: 34856889 DOI: 10.1080/07391102.2021.2009915] [Reference Citation Analysis]
5 Chew H, Solomon VA, Fonteh AN. Involvement of Lipids in Alzheimer's Disease Pathology and Potential Therapies. Front Physiol 2020;11:598. [PMID: 32581851 DOI: 10.3389/fphys.2020.00598] [Cited by in Crossref: 31] [Cited by in F6Publishing: 22] [Article Influence: 15.5] [Reference Citation Analysis]
6 Romanenko M, Kholin V, Koliada A, Vaiserman A. Nutrition, Gut Microbiota, and Alzheimer's Disease. Front Psychiatry 2021;12:712673. [PMID: 34421687 DOI: 10.3389/fpsyt.2021.712673] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Torres M, Parets S, Fernández-Díaz J, Beteta-Göbel R, Rodríguez-Lorca R, Román R, Lladó V, Rosselló CA, Fernández-García P, Escribá PV. Lipids in Pathophysiology and Development of the Membrane Lipid Therapy: New Bioactive Lipids. Membranes (Basel) 2021;11:919. [PMID: 34940418 DOI: 10.3390/membranes11120919] [Reference Citation Analysis]
8 Białecka-dębek A, Granda D, Pietruszka B. The role of docosahexaenoic acid (DHA) in the prevention of cognitive impairment in the elderly. Postepy Hig Med Dosw 2021;75:345-61. [DOI: 10.5604/01.3001.0014.8986] [Reference Citation Analysis]
9 Fonteh AN, Chiang AJ, Arakaki X, Edminster SP, Harrington MG. Accumulation of Cerebrospinal Fluid Glycerophospholipids and Sphingolipids in Cognitively Healthy Participants With Alzheimer's Biomarkers Precedes Lipolysis in the Dementia Stage. Front Neurosci 2020;14:611393. [PMID: 33390893 DOI: 10.3389/fnins.2020.611393] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]